Chemed Corp New (CHE) Shareholder Van Berkom & Associates INC Decreased Its Stake as Shares Rose

June 27, 2018 - By Joseph Taylor

Big Money Sentiment is 0.96 in Q1 2018. It has change of 2017Q4’s as. The ratio is flat due to CHE positioning: 26 sold and 90 reduced. only 41 funds acquired positions and 70 increased positions. Investors holded 14.86 million in 2017Q4 but now own 14.70 million shares or 1.09% less. Acadian Asset Lc stated it has 575,660 shs or 0.68% of all its holdings. Ajo LP holds 36,220 shs or 0.05% of its capital. Neuberger Berman Grp Incorporated Limited Liability Company has invested 0.28% in Chemed Corporation (NYSE:CHE). Campbell And Invest Adviser Ltd has 942 shs. Comerica Bancorp reported 17,004 shs stake. Moreover, Tiaa Cref Invest Management Limited Liability has 0.01% invested in Chemed Corporation (NYSE:CHE). 14,135 are owned by First Trust Advsrs Lp. Lpl Finance Limited Liability Company reported 0% of its capital in Chemed Corporation (NYSE:CHE). Coldstream Management Incorporated holds 0.03% or 1,146 shs. Louisiana State Employees Retirement Systems owns 7,200 shs or 0.09% of their US capital. Etrade Mngmt Lc owns 2,579 shs. Deutsche National Bank Ag holds 0.01% or 30,610 shs in its capital. Oppenheimer Asset Mngmt Inc has invested 0.13% in Chemed Corporation (NYSE:CHE). Paloma Prtnrs Management holds 0% or 866 shs in its capital. Old Mutual Investors (Uk) accumulated 87,190 shs or 0.19% of the stock.

CHE had 17 selling transactions and 0 buys since January 12, 2018. This’s net activity of $34.61 million. On Tuesday, April 24 the insider WILLIAMS DAVID PATRICK sold $4.74M. Another trade for 300 shs valued at $91,476 was made by Dallob Naomi C on Tuesday, April 24. On Wednesday, May 16 LEE SPENCER S had sold 1,440 shs worth $478,397. Shares for $80,940 were sold by GRACE PATRICK P on Friday, June 22. On Thursday, April 26 352 shs were sold by SAUNDERS DONALD E, worth $107,864. $4.04 million worth of Chemed Corporation (NYSE:CHE) shs were sold by Westfall Nicholas Michael.

According to 2018Q1 Securities and Exchange form the Van Berkom & Associates Inc decreased its holdings in Chemed Corp New (CHE) by 9.32%. The company’s stock popped up 24.64% while Van Berkom & Associates Inc sold 35,587 shares. The institutional investor is holding 346,383 shares, compared to the 381,970 from the previous quarter. And the reported value of the medical and nursing services company is $94.51M for the 2018Q1. Chemed Corp New has $5.12 billion MC. CHE is reaching $321.29 during the last trading session, after decreased 0.79%.Currently Chemed Corporation is uptrending after 61.23% change in last June 27, 2017. CHE has also 57,036 shares volume. The stock outperformed the S&P500 by 48.66%.

About $3.36B and $3.30B US Long portfolio Van Berkom & Associates Inc manages. Its stake in Dxp Enterprises Inc New (NASDAQ:DXPE) was increased by 166,275 shares to 1.02 million shares valued at $39.85 million in 2018Q1, according to the filing. For a total of 1.30M shares it increased its holding in Tempur Sealy Intl Inc (NYSE:TPX) by 214,642 shares in the quarter, and has risen its stake in Ambarella Inc (NASDAQ:AMBA).

On July, 24. Investors wait Chemed Corporation (NYSE:CHE) to announce its quarterly earnings, according to RTT. Analysts expect change of 24.65 % or $0.53 from previous year’s $2.15 earnings per share compared to current’s $2.68 earnings per share. CHE’s profit could reach $42.72M if the current earnings per share of $2.68 is accurate. Wall Street now predicts -1.47 % negative EPS growth despite Chemed Corporation last quarter’s EPS of $2.72.

Another two news for Chemed Corporation (NYSE:CHE) were recently released by: on June 08, 2018 with title “S&P indexes swap firms due to shifting market caps; FSB to SmallCap 600”. The other‘s article was titled “VITAS HEALTHCARE TO ATTEND AHIP INSTITUTE & EXPO 2018” and released on June 21, 2018.

Chemed Corporation (NYSE:CHE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.